ArticleOncoimmunology2025

CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183-91/HLA-A *0201 exhibit potent activity against HBV-HCC.

Fengling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.